Diabetes News and Research

Latest Diabetes News and Research

HealthWyse, Cardiocom partner to integrate patient information into clinical software

HealthWyse, a leading provider of home health and hospice software and services, announced today that it has partnered with Cardiocom, a leader in home telehealth solutions, to seamlessly integrate patient information into HealthWyse's clinical software.

13 Sep 2010

AultCare reports positive results from Cardiocom program

AultCare has been using patient telemonitoring for six years and has, in partnership with Cardiocom, released a white paper entitled, "AultCare Sees Positive Results from Cardiocom Program."

13 Sep 2010

Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA

An antibiotic appears to be a safe treatment for stroke and a good companion therapy for tPA, the clot buster that is currently the only FDA-approved drug therapy, researchers report.

13 Sep 2010

Genomas awarded method patent for PhyzioGenomics Technology

Genomas®, a biomedical company advancing DNA-Guided Medicine, has been awarded US Patent 7,747,392, entitled Physiogenomic Method for Predicting Clinical Outcomes of Treatment in Patients by the US Patent and Trademark Office.

13 Sep 2010

Relypsa completes $70M Series B financing

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced the completion of a Series B financing totaling $70 million. OrbiMed Advisors, LLC, led the financing with participation from existing Relypsa investors New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, Sprout Group and Mediphase Venture Partners.

13 Sep 2010

Geron, UCS collaborate to develop hESC-derived chondrocytes for cartilage damage, joint disease treatment

Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.

13 Sep 2010

Jennerex reports positive interim data from trial of JX-594 and sorafenib for liver cancer

Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.

13 Sep 2010

Geron signs worldwide, exclusive license agreement with University of Edinburgh

Geron Corporation today announced that it has entered into a worldwide, exclusive license agreement with the University of Edinburgh covering technology that allows the efficient production of chondrocytes (cartilage forming cells) from human pluripotent stem cells.

13 Sep 2010

JDRF selects Convio's Common Ground CRM for primary constituent relationship management

Convio, Inc. announced today that Juvenile Diabetes Research Foundation (JDRF) has selected Convio as their standard for constituent relationship management (CRM), online marketing and fundraising, and special events for JDRF's national headquarters and all chapters. JDRF will use Convio's integrated, on-demand marketing, fundraising and advocacy suite to power and support their efforts to engage constituents and raise money.

13 Sep 2010

Six California-based institutions collaborate to guide CDU

Six California-based institutions specializing in health, hospital, university and nonprofit health announced today the formation of a new and unprecedented collaboration effort to rescue, restructure, reinvigorate and guide Charles R. Drew University of Medicine and Science (CDU) towards a new, resurgent and financially viable future.

13 Sep 2010

Santarus expands development pipeline, adds two novel biologic drug candidates

Santarus, Inc., a specialty biopharmaceutical company, has expanded its development pipeline with the addition of two novel biologic drug candidates focused on specialty markets.

13 Sep 2010

Diamyd Medical reports potential results on NP2 Phase I clinical trial for chronic pain

Diamyd Medical AB, to date no drug related Serious Adverse Events have been reported by any patient included in Diamyd's Phase I clinical trial investigating NP2 as a potential therapy for chronic pain. Based upon the Phase I findings to date, the company is planning a multi-center, randomized, double-blind, placebo controlled Phase II clinical trial with NP2 in the United States.

13 Sep 2010

Scientists discover SNP association with primary open-angle glaucoma risk

Scientists at deCODE genetics and academic colleagues from Iceland, China, Sweden, the UK and Australia today report the discovery of the most important single-letter variation (SNP) in the sequence of the human genome yet associated with risk of primary open-angle glaucoma. This is the most common form of glaucoma and a major cause of blindness worldwide.

13 Sep 2010

Oral health impacts systemic diseases: Report

It's not news that there is a significant link between one's oral health and overall health. Though studies are ongoing, researchers have known for quite some time that the mouth is connected to the rest of the body.Your mouth is the entry point of many bacteria,said Dr. Steven Grater, Pennsylvania Dental Association (PDA) member and general dentist from Harrisburg. To keep this bacteria from going into your body, cleaning your mouth (brushing, flossing and rinsing) is necessary.

13 Sep 2010

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

A drug developed at the University of Kansas has the potential to stop a debilitating condition of diabetes that often leads to pain in the extremities and even amputations, KU researchers have found.

13 Sep 2010

Study shows attaching prostheses to titanium implant improves quality of life

Today sees the presentation of a study that, for the first time, shows the results of treatment using prostheses attached to titanium implants in the bones of patients with above-the-knee amputations. It reveals that the treatment improves function and quality of life in nine out of ten patients, and is the result of research carried out at the Sahlgrenska Academy and Sahlgrenska University Hospital that is being presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.

13 Sep 2010

Dartmouth study says primary care not always a cure-all

A new study by Dartmouth Health Atlas researchers contends that making primary care more widely accessible -- one of the goals of the health overhaul -- won't necessarily improve the nation's health, Reuters reports. The researchers found wide variations in the quality of care that do not always match up with the level of access to physicians.

10 Sep 2010

Resverlogix announces key changes to Phase 2 ASSURE trial

Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.

10 Sep 2010

Clinica of Virginia offers medical services to Medicare and Medicaid patients for $1.00

In an effort to promote wellness and help those who are struggling to make ends meet, Clinica of Virginia, LLC. is providing quality medical services to Medicare and Medicaid patients for only $1.00. The national economic downturn, combined with national bureaucracy, has created a shortage of physicians and clinics who accept Medicare and Medicaid. Chronic, multiple medical conditions plague those Americans who can financially afford it the least, and physicians' offices who accept Medicare or Medicaid are now far and few between. Clinica accepts both.

10 Sep 2010

Appeals Court ruled that Feds can temporarily fund stem cell research

The Washington Post: "An appeals court ruled Thursday that the federal government can resume funding human embryonic stem cell research while the court reviews a judge's order that had temporarily prohibited such funding. A three-judge panel of the U.S. Court of Appeals for the D.C. Circuit granted a request from the Justice Department to lift a temporary injunction issued Aug. 23 blocking the funding on the grounds that it violated a law barring funding any research that involves the destruction of human embryos.

10 Sep 2010

Diabetes News and Research

Latest Diabetes News and Research

HealthWyse, Cardiocom partner to integrate patient information into clinical software

AultCare reports positive results from Cardiocom program

Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA

Genomas awarded method patent for PhyzioGenomics Technology

Relypsa completes $70M Series B financing

Geron, UCS collaborate to develop hESC-derived chondrocytes for cartilage damage, joint disease treatment

Jennerex reports positive interim data from trial of JX-594 and sorafenib for liver cancer

Geron signs worldwide, exclusive license agreement with University of Edinburgh

JDRF selects Convio's Common Ground CRM for primary constituent relationship management

Six California-based institutions collaborate to guide CDU

Santarus expands development pipeline, adds two novel biologic drug candidates

Diamyd Medical reports potential results on NP2 Phase I clinical trial for chronic pain

Scientists discover SNP association with primary open-angle glaucoma risk

Oral health impacts systemic diseases: Report

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Study shows attaching prostheses to titanium implant improves quality of life

Dartmouth study says primary care not always a cure-all

Resverlogix announces key changes to Phase 2 ASSURE trial

Clinica of Virginia offers medical services to Medicare and Medicaid patients for $1.00

Appeals Court ruled that Feds can temporarily fund stem cell research

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in